Ross Bentley

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

Krista Goodman, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 154 citations · Full text

Indazole Substitution, Medicinal Chemistry, Oral Bioavailability +11

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

Paul J. Silver, L T Hamel, Mark H. Perrone et al. · European Journal of Pharmacology · 1988 · 109 citations

Molecular Pharmacology, Cardiac Muscle, Biochemistry +5

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

Weike Bao, David J. Behm, Sandhya S. Nerurkar et al. · Journal of Cardiovascular Pharmacology · 2007 · 98 citations

Hypertension, Cardiovascular Pharmacology, P38 Mapk +17

Discovery of an Orally Efficacious Inhibitor of Coagulation Factor Xa Which Incorporates a Neutral P₁Ligand

Yong Mi Choi-Sledeski, Robert E. Kearney, Gregory Poli et al. · Journal of Medicinal Chemistry · 2003 · 78 citations · Full text

Orally Efficacious Inhibitor, Pharmaceutical Science, Pharmacotherapy +18